DUBLIN--(BUSINESS WIRE)--Jun 14, 2018--The "Global Seborrheic Keratosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

The global seborrheic keratosis treatment market is expected to reach US$ 1,320.8 million by 2026. Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market.

Although surgical treatments are available in the market to treat seborrheic keratosis, a topical solution (40% hydrogen peroxide - Eskata by Aclaris Therapeutics) was approved by the FDA in 2017, which may augment the market growth due to expected improvement in treatment adherence.

Furthermore, Aclaris Therapeutics has also filed an application in the European regulatory agencies for approval. The approval of the topical solution along with the ongoing research for other therapeutics will contribute to the growth of the seborrheic keratosis treatment market during the forecast period.

The global seborrheic keratosis treatment market is segmented into surgical treatments and topical solution treatments. Surgical treatments segment is further categorized into cryosurgery, electrocautery, curettage, and laser ablation. Topical solution treatment segment includes the currently approved 40% hydrogen peroxide solution.

While destructive treatments such as cryotherapy and curettage will remain the gold standard for seborrheic keratosis treatment, new therapies such as laser beam treatment and topical applications are anticipated to achieve more efficiency with comfort and convenience for patients.

Key Topics Covered

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Global Seborrheic Keratosis Treatment Market: Market Dynamics and Future Outlook

Chapter 4. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2016-2026 (US$ Mn)

Chapter 5. Global Seborrheic Keratosis Treatment Market, by Geography, 2016-2026 (US$ Mn)

Chapter 6. Company Profiles

Aclaris Therapeutics, Inc. Cortex Technology ApS CryoConcepts LP Cryoswiss GmbH DRE Medical, Inc. EpiPharm AG H&O Equipments SA Orasure Technologies, Inc. Special Medical Technology Co., Ltd. Wallach Surgical Devices, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/b62mr7/global_seborrheic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180614006238/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/14/2018 04:44 PM/DISC: 06/14/2018 04:43 PM

http://www.businesswire.com/news/home/20180614006238/en